Download Files:
DB2115 (tertahydrochloride)
$350 – $2,500
Products Details
Product Description
– DB2115 (tertahydrochloride) is a potent inhibitor of myeloid master regulator PU.1. DB2115 (tertahydrochloride) has the potential for researching cancers, including hematologic cancers such as leukemia, as well as other conditions associated with PU. 1 dysfunction (extracted from patent WO2017223260A1, compound DB2115) [1].
Web ID
– HY-124676A
Storage Temperature
– 4°C (Powder, sealed storage, away from moisture)
Shipping
– Room Temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C32H34Cl4N8O2
References
– [1]W. David Wilson, et al. Pu.1 inhibitors. Patent WO2017223260A1.
CAS Number
– 1366126-19-3
Molecular Weight
– 704.48
Compound Purity
– 99.31
SMILES
– N=C(C1=CC=C2N=C(C3=CC=C(OCCCCOC4=CC=C(C5=NC6=CC=C(C(N)=N)C=C6N5)C=C4)C=C3)NC2=C1)N.[H]Cl.[H]Cl.[H]Cl.[H]Cl
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– DMSO : 15.85 mg/mL (ultrasonic;warming;adjust pH to 4 with HCl;heat to 60°C)
Target
– Apoptosis
Pathway
– Apoptosis
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
